13 results found.

Opiate Dependence Clinical Trial using very low dose naltrexone; extended release naltrexone; buprenorphine/naloxone

Duke University - Recruiting 18 years to 65 years.
- An Open Label, Flexible Dose Study of Very Low Doses of Naltrexone-Buprenorphine Transfer to Extend-Release Naltrexone (VIVITROLr) in Opioid Addiction.
very low dose naltrexone; extended release naltrexone; buprenorphine/naloxone

Opioid Dependence, on Agonist Therapy Clinical Trial using OX219; Suboxone film; Buprenorphine

Orexo AB - Recruiting 18 years to 65 years.
- Induction, STabilization, Adherence and Retention Trial (ISTART) - A Randomized Non-inferiority Multicenter Study to Assess Early Treatment Efficacy of OX219 Versus SUBOXONE Film and to Explore Switching Between Treatments.
OX219; Suboxone film; Buprenorphine

Opioid Dependence, on Agonist Therapy Clinical Trial using buprenorphine/naloxone

Orexo AB - Recruiting 18 years to 65 years.
- A Multi-center, Open-label, 24-week, Follow-up Study to Assess Safety, Efficacy and Treatment Adherence for Maintenance Treatment of Opioid Dependence With OX219.
buprenorphine/naloxone

Substance Abuse, Opioid Dependence, or Methadone Treatment Clinical Trial using Oxytocin; Saline Nasal Spray

University of California, San Francisco - Recruiting 18 years or older.
- The Effects of Intranasal Oxytocin on Social Cognition and Social Approach Behaviors in Opioid-dependent Patients Receiving Methadone Treatment.
Oxytocin; Saline Nasal Spray

Opioid Dependence Clinical Trial using Medsignals; smartphone app

Care Team Solutions - Recruiting 21 years or older.
- Using mHealth to Aid Opioid Medication Adherence Pilot Study.
Medsignals; smartphone app

Opioid Dependence Clinical Trial using oral naltrexone; Buprenorphine; Vivitrol

New York State Psychiatric Institute - Recruiting 18 years to 60 years.
- Long-acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone vs. Buprenorphine.
oral naltrexone; Buprenorphine; Vivitrol

Opioid Dependence Clinical Trial using Isradipine; Placebo

University of Arkansas - Recruiting 18 years to 65 years.
- Improving Buprenorphine Detoxification Outcomes With Isradipine.
Isradipine; Placebo

Opioid Dependence, Pain, or Addiction Clinical Trial using Placebo; Hydromorphone; Buprenorphine

Johns Hopkins University - Recruiting 18 years to 55 years.
- Analgesic Effects and Abuse Liability of Intravenous Hydromorphone and Buprenorphine in Pain-free Opioid Dependent Participants.
Placebo; Hydromorphone; Buprenorphine

Cigarette Smoking Among Patients Currently Receiving Methadone or Clinical Trial using incentive-based contingency management

Fletcher Allen Health Care - Recruiting 18 years to 65 years.
- Incentive-based Smoking Cessation for Methadone Patients.
incentive-based contingency management

Opioid Dependence Clinical Trial using Fentanyl

University of Adelaide - Recruiting 18 years to 65 years.
- An Assessment of Fentanyl Dose Requirements in Opioid-maintained Individuals.
Fentanyl

Opioid Dependence, or Injection Drug Use Clinical Trial using Community-based buprenorphine treatment (CBBT) intervention

Albert Einstein College of Medicine of Yeshiva University - Recruiting 18 years or older.
- Development of a Community-based Buprenorphine Treatment Intervention.
Community-based buprenorphine treatment (CBBT) intervention

HIV, AIDS, Opioid Dependence, or Drug Dependence Clinical Trial using Depot Naltrexone

Yale University - Recruiting 18 years or older.
- Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations.
Depot Naltrexone

Substance Withdrawal Syndrome Clinical Trial

Banner Health - Recruiting N/A to 18 years.
- Validation of a Pediatric Abstinence Syndrome Scoring Tool Utilizing a Standardized Hospital-Based Guideline for Iatrogenic Opioid Dependence.